Security Snapshot

Minerva Neurosciences, Inc. - Common Stock (NERV) Institutional Ownership

CUSIP: 603380205

13F Institutional Holders and Ownership History from Q2 2022 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

58

Shares (Excl. Options)

42.32MFull value: 42,318,900 · shares · 30 Jun 2026

Price

$5.55

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+3,920,804
Value change
+$21,127,751
Number of holders
58
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
48,044,784
SEC-reported price per share
$3.35
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • NERV - Minerva Neurosciences, Inc. - Common Stock is tracked under CUSIP 603380205.
  • 58 institutions reported positions in Q2 2026.
  • 9 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 43 to 58 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from
    $230.78MFull value: $230,775,656 · USD · 31 Mar 2026
    to
    $234.82MFull value: $234,815,421 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 58 institutions filings for Q2 2026.

Open SEC evidence

Security key

603380205

13F reference period

Q2 2026

13F holders

58

13D/G owners

9

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
9
Security
NERV
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FEDERATED HERMES, INC. 17% -13% $40,152,078 -$3,240,232 8,690,926 -7.5% Federated Hermes, Inc. 30 Jun 2026
Vivo Opportunity Fund Holdings, L.P. 10% $32,476,142 8,591,572 Vivo Opportunity Fund Holdings, L.P. 23 Dec 2025
FARALLON CAPITAL MANAGEMENT, L.L.C. 9.7% $23,271,600 4,730,000 Farallon Capital Management, L.L.C. 30 Jun 2026
BALYASNY ASSET MANAGEMENT L.P. 10% 0% $22,898,723 +$1,593,573 4,654,212 +7.5% BALYASNY ASSET MANAGEMENT L.P. 30 Jun 2026
Coastlands Capital LP 10% $18,571,536 4,563,031 Coastlands Capital LP 13 Feb 2026
Farallon Capital Partners, L.P. 10% 0% $18,250,213 4,539,854 0% Dapice Joshua J. 31 Dec 2025
Logos Global Management LP 9.9% $18,407,093 4,435,444 Logos Global Management LP 23 Dec 2025
Adage Capital Management, L.P. 6.4% $11,777,700 2,838,000 Adage Capital Management, L.P. 31 Dec 2025
BlackRock, Inc. 5.1% $8,209,432 2,450,284 BlackRock, Inc. 30 Sep 2026
As of 30 Jun 2026, 58 institutional investors reported holding
42.32MFull value: 42,318,900 · shares · 30 Jun 2026
shares of Minerva Neurosciences, Inc. - Common Stock (NERV). This represents 88% of the company’s total
48.04MFull value: 48,044,784 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
87%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FEDERATED HERMES, INC. 9.7% 4,670,426 -8.7% 0.04% $25,920,864
Jupiter Topco LLC 9.1% 4,386,027 0% 0.01% $24,320,520
Vivo Capital, LLC 9% 4,322,747 0% 2.2% $23,991,246
Balyasny Asset Management L.P. 8.9% 4,257,000 -0.04% 0.04% $23,626,350
Logos Global Management LP 6.8% 3,288,777 +2.3% 0.79% $18,252,712
FARALLON CAPITAL MANAGEMENT, L.L.C. 4.9% 2,365,000 0% 0.08% $13,125,750
BlackRock, Inc. 4.7% 2,240,578 +259% 0% $12,435,208
Ally Bridge Group (NY) LLC 4.5% 2,175,802 +31% 16% $12,075,701
Foresite Capital Management VI LLC 4.1% 1,985,584 -0.05% 1.7% $11,019,991
VANGUARD CAPITAL MANAGEMENT LLC 3.9% 1,892,807 +2.5% 0% $10,505,079
Spruce Street Capital LP 3.4% 1,655,500 0% 1.8% $9,188,025
Trails Edge Capital Partners, LP 3% 1,419,000 0% 1.3% $7,875,450
ADAGE CAPITAL PARTNERS GP, L.L.C. 3% 1,419,000 0% 0.01% $7,875,450
Seven Fleet Capital Management LP 2.1% 1,001,373 +303% 0.92% $5,557,620
GEODE CAPITAL MANAGEMENT, LLC 2% 974,236 +188% 0% $5,408,947
DV EQUITIES, LLC 1.6% 754,397 0.61% $4,186,903
ACUTA CAPITAL PARTNERS, LLC 1.5% 709,500 0% 2.7% $3,937,725
MILLENNIUM MANAGEMENT LLC 1.1% 533,602 -25% 0% $2,961,491
STATE STREET CORP 0.88% 424,915 +654% 0% $2,358,278
VANGUARD FIDUCIARY TRUST CO 0.63% 302,604 +15% 0% $1,679,452
NORTHERN TRUST CORP 0.61% 292,117 +213% 0% $1,621,249
VANGUARD PORTFOLIO MANAGEMENT LLC 0.49% 234,754 0% $1,302,885
GOLDMAN SACHS GROUP INC 0.3% 143,954 +350% 0% $798,945
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.24% 113,625 +267% 0% $630,619
Bank of New York Mellon Corp 0.16% 75,580 0% $419,468

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
18
Headline period
Q2 2026
Rows shown
1-18 of 18
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 43,779 $143,281 -$355,723 $3.35 4
2026 Q2 42,318,900 $234,815,421 +$21,127,751 $5.55 58
2026 Q1 38,297,681 $230,775,656 +$54,667,446 $6.02 43
2025 Q4 23,063,409 $90,576,655 +$76,545,252 $4.02 29
2025 Q3 1,979,675 $4,208,645 +$81,860 $2.10 22
2025 Q2 1,944,466 $3,341,879 -$12,369 $1.72 18
2025 Q1 1,951,817 $3,310,087 -$310,831 $1.70 19
2024 Q4 2,085,897 $4,630,050 -$81,975 $2.22 21
2024 Q3 2,118,026 $5,654,665 +$83,536 $2.67 19
2024 Q2 2,086,302 $6,654,936 -$42,908 $3.19 20
2024 Q1 2,099,790 $5,416,495 -$2,569,915 $2.58 20
2023 Q4 2,415,482 $14,854,825 +$68,371 $6.15 19
2023 Q3 2,403,051 $16,580,809 +$303,012 $6.90 19
2023 Q2 2,352,300 $19,044,605 +$5,865,507 $9.14 18
2023 Q1 1,680,901 $2,687,500 -$78,110 $1.60 14
2022 Q4 1,729,786 $2,748,707 -$3,027,635 $1.59 17
2022 Q3 2,028,914 $18,733,000 -$1,898,373 $9.24 23
2022 Q2 2,269,165 $7,508,000 +$7,508,000 $3.31 20
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .